Sapien
Sapien builds an AI platform that connects financial results with the operational decisions behind them.
UndisclosedNeo-led financing
LeadN
Neo
Activity from announced rounds
Activity in this selectionOct 29, 2026 · Enterprise software · Jan 1, 2026
Neo is an early-stage technology investor whose Neo Residency brings startup founders and student builders into a shared company-building programme in San Francisco.
Introduced in February 2026, the residency combines three months of San Francisco workspace, a two-week Oregon bootcamp and individual mentorship. It replaced Neo Accelerator and Semester in SF, bringing their participants into a single cohort.
The announced startup offer is $750,000 on uncapped terms, with participation rights of up to 5% in the next equity round. The student route offers a $40,000 grant per person. Founders and students also receive a profit share in Neo’s fund, linking part of their outcome to the wider cohort’s success.
Sources
- Rounds participated in
- 7
- Confirmed lead rounds
- 1 3 roles undisclosed
- New companies
- 7 First participation on record · 0 follow-on
- Funding in participating rounds
- $348M 5 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
7 in this selectionTransfyr
Physical AI platform capturing real-world lab science into machine-readable data
$25MSeed
Role not disclosedTwin1 AI
Gives professionals AI-powered digital twins that scale their expertise securely
$20MSeed
Role not disclosedWispr Flow
Wispr Flow turns speech into edited text across desktop and mobile applications and provides AI notes for meetings.
$280MSeries B
ParticipantCourtroom
Simulates juror and judge perspectives to help litigation teams sharpen case strategy before trial
UndisclosedPre-Seed
Role not disclosedAltara
AI software for scientists and engineers improving experiments, product quality and manufacturing yield.
$7MSeed
ParticipantAmperos Health
Amperos Health combines AI collections workflows and revenue-cycle specialists to recover unpaid insurance claims for healthcare providers.
$16MSeries A
Participant